<DOC>
	<DOCNO>NCT00773227</DOCNO>
	<brief_summary>The OCULO-Pharyngeal Muscular Dystrophy ( OPMD ) late onset hereditary muscle disease characterise selective affection pharyngeal muscle result swallow disorder , ptosis dysfunction levator palpebral superior muscle . Swallowing disorder determinant prognosis disease , potentially life-threatening deglutition , due aspiration denutrition . Degenerative dystrophy pharyngeal muscle cause difficulty prepulse food bolus pharynx , decrease relaxation cricopharyngeal muscle induce disease lead blockage food upper esophageal sphincter . The common treatment dysphagia OPMD myotomy upper esophageal sphincter muscle . However , although relax constriction upper esophageal sphincter muscle improve transitory swallowing , prevent progressive degradation pharyngeal muscle . This progressive loss contractility eventually result aspiration severe difficulty swallowing , increase risk aspiration pneumonia severe weight loss common cause mortality OPMD patient . The protocol propose graft autologous cell muscle ( myoblasts ) isolate unaffected limb muscle pharyngeal muscle patient diagnose suffer OPMD . Our aim improve swallow contractile deficit generate dystrophic pharyngeal muscle . A myotomy upper esophageal sphincter carry time myoblast transplantation , since already validate improvement result surgery . Advantages new therapy OPMD autograft , without risk rejection , graft myoblasts dystrophic pharyngeal muscle , myotomy upper esophageal sphincter muscle . This model cellular therapy study preclinical study perform dog , allow valid procedure safety , well study survival myoblasts graft pharyngeal muscle . This protocol propose OPMD patient ; firstly safety study autograft surgical procedure . In addition , autograft may improve swallow disorder life-threatening complication induce aspiration weight loss , result potential individual benefit .</brief_summary>
	<brief_title>Treatment Dysphagia Oculopharyngeal Muscular Dystrophy Autologous Transplantation Myoblasts</brief_title>
	<detailed_description>OCULO-Pharyngeal Muscular Dystrophy ( OPMD ) characterise selective affection superior sphincter muscle oesophagus ( SSO ) pharyngeal.muscles result dysphagia . The common treatment dysphagia induce disease myotomy . However , although relax constriction improve swallow prevent progressive degradation pharyngeal muscle . This progressive loss contractility eventually result false route severe difficulty swallowing , increase risk pulmonary infection severe weight loss common cause mortality patient . Concept : The protocol propose pilot study autologous myoblasts isolate unaffected limb muscle graft pharyngeal constrictor muscle patient diagnose suffer OPMD . Our aim improve swallow contractile deficit generate dystrophic pharyngeal constrictor muscle . A myotomy SSO carry time myoblast transplantation , since already validate improvement result surgery even though know provide partial transitory improvement . Type trial : This multicentric trial direct benefit patient 10 patient receive autologous transplantation myoblasts . Due possibility certain number patient may withdraw study decide include initially maximum 15 patient . The PHRC clinical trial accept 2002 official promotor AP-HP . The patient select different promotors follow 'Service d'ORL TENON Hospital ' . The proliferative capacity myoblasts isolate muscle biopsy carry Vincent MOULY KAMEL MANCHAOUI UMR 7000 CNRS direct Dr Butler-Browne cell amplify prior graft Cellular laboratory therapy Dr MAROLLEAU ; The clinical trial control specifically select committee five . Description trial In first step study patient select inclusion trial accord follow criterion : 1 : men woman age 18 75 year ; 2 : genetic confirmation characterisation OPMD 3 : SSO dysfunction confirm stasis saliva food sphincter visualise fibroscopy defect opening SSO also confirm videofluoroscopy swallowing ; SSO defect may associate reduction pharyngeal propulsion reveal fibroscopy videofluoroscopy swallow 4 : official sign consent patient participate clinical trial . The next step selection unaffected muscle use production autologous myoblasts use transplantation . Muscles select engraftment basis proliferative capacity culture make biopsy ( 0.5-1gm ) obtain follow local anesthesia either quadriceps STERNO-CLEIDO-MASTOIDIEN muscle . The muscle able produce large number myoblasts biopsied second time use condition . Two gram muscle remove myoblasts isolate culture 100 million myoblasts point cell inject pharyngeal muscle patient . If difference two different muscle biopsy biopsy preferentially STERNO-CLEIDO-MASTOIDIEN muscle since situate directly trajectory use grafting myoblasts . The operation lateral cervicotomy carry general anesthesia , order expose SSO pharyngeal muscle . The graft carry injecting myoblasts 20 different site pharyngeal constrictor muscle site associate myotomy SSO . The next step involve two year evaluation trial . For patient descriptive analysis carry base comparison different result . The principal evaluation efficiency graft base functional quality pharyngeal propulsion determine fibroscopy videofluoroscopy swallowing . A secondary evaluation base global swallowing property evaluate quantitative test , questionnaire evaluation tolerance . This evaluation include clinical examination visit consist examination pharynx order confirm absence muscle tumor cervical palpation order determine volume muscle survey site myoblasts implantation . A rigid tube pharyngeal endoscopy carry general anesthesia 6 12 month graft case abnormal pharynx fibroscopy . In addition , global neuromuscular examination carry annual basis follow general evolution myopathy . The fibroscopy determine swallow function , global quantitative tesy swallow questionnaire carry 2 , 6 24 month graft . A videofluoroscopy swallow carry 2 month 1 2 year graft . Risks Benefits : The principal benefit patient could envision procedure delay deterioration pharyngeal muscle associate disease consequently improvement difficulty swallow usually associate disease . The potential risk associate type operation inflammatory reaction , appearance tumor lack improvement symptom associate disease . A parallel preclinical study carry dog order evaluate tolerance feasibility procedure autografting myoblasts pharyngeal muscle .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Deglutition Disorders</mesh_term>
	<mesh_term>Muscular Dystrophy , Oculopharyngeal</mesh_term>
	<criteria>Man woman &lt; 1875 &gt; year old Oculopharyngeal muscular dystrophy confirm genetic diagnosis ( mutation GCG ) chromosome 14 ) Oculopharyngeal muscular dystrophy UES dysfunction 1. salivary alimentary stasis fibroscopy swallow UES , 2. decrease open UES videofluoroscopy swallow A decreased pharyngeal propulsion may associate Written consent patient History myotomy UES context Oculopharyngeal muscular Dystrophy ; HIV , hepatitis B C tuberculosis ) ; Lupus , rheumatoid polyarthritis , sarco√Ødosis , collagenosis ) ; Other neuromuscular disease ; History malignant tumor ; History neck radiotherapy ; Renal failure ( creatinine clearance &lt; 60ml/min ) Liver failure ; Pregnancy ; Follow le 24 month : Patients refuse sign consent ; No social security .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Oculopharyngeal muscular dystrophy</keyword>
	<keyword>Swallowing disorder , dysphagia</keyword>
	<keyword>Pharyngeal propulsion</keyword>
	<keyword>Upper oesophageal sphincter</keyword>
	<keyword>Cricopharyngeal muscle</keyword>
	<keyword>Autologous myoblasts</keyword>
	<keyword>Autograft</keyword>
	<keyword>Myotomy upper oesophageal sphincter</keyword>
	<keyword>Fibroscopy swallow</keyword>
	<keyword>Videofluoroscopy swallow</keyword>
</DOC>